Cargando…
MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons
Embryonal tumors of the central nervous system represent a heterogeneous group of childhood cancers with an unknown pathogenesis; diagnosis, on the basis of histological appearance alone, is controversial and patients’ response to therapy is difficult to predict. They encompass medulloblastoma, atyp...
Autores principales: | Shalaby, Tarek, Fiaschetti, Giulio, Baumgartner, Martin, Grotzer, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264241/ https://www.ncbi.nlm.nih.gov/pubmed/25421247 http://dx.doi.org/10.3390/ijms151121554 |
Ejemplares similares
-
Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors
por: Shalaby, Tarek, et al.
Publicado: (2014) -
G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors
por: Shalaby, Tarek, et al.
Publicado: (2013) -
Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies
por: Shalaby, Tarek, et al.
Publicado: (2015) -
Electrochemical Biosensors for Detection of MicroRNA as a Cancer Biomarker: Pros and Cons
por: El Aamri, Maliana, et al.
Publicado: (2020) -
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014)